InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by Feener Edward P., Chief Scientific Officer. Officer active across 1 companies, notably KalVista Pharmaceuticals, Inc.. Aggregated, 12 reports have been published. Total volume traded: €1.8m. The latest transaction was filed on 7 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€211,53333,800 shares@ €6.25840.015% mcap19.3% of flow
Common Stock
SEC:0001209191-22-002887·
€211,53333,800 shares@ €6.25840.015% mcap9.4% of flow
Common Stock
SEC:0001209191-22-002887:0·
€93,8196,000 shares@ €15.63650.0066% mcap8.5% of flow
Common Stock
SEC:0001209191-21-062736·
€93,8196,000 shares@ €15.63650.0066% mcap4.2% of flow
Common Stock
SEC:0001209191-21-062736:0·
€103,6956,000 shares@ €17.28240.0073% mcap9.4% of flow
Common Stock
SEC:0001209191-21-049799·
€103,6956,000 shares@ €17.28240.0073% mcap4.6% of flow
Common Stock
SEC:0001209191-21-049799:0·
€565,80225,786 shares@ €21.94220.040% mcap51.5% of flow
Common Stock
SEC:0001209191-21-037887·
€565,80225,786 shares@ €21.94220.040% mcap25.2% of flow
Common Stock
SEC:0001209191-21-037887:0·
€123,5786,000 shares@ €20.59630.0087% mcap11.3% of flow
Common Stock
SEC:0001209191-21-031013·
€123,5786,000 shares@ €20.59630.0087% mcap5.5% of flow
Common Stock
SEC:0001209191-21-031013:0·
6,000 shares
Common Stock
SEC:0001209191-21-030753·
€50,7916,000 shares@ €8.46510.0036% mcap2.3% of flow
Common Stock
SEC:0001209191-21-030753:0·
12 of 12 declarations
About Feener Edward P.
Edward P. Feener is the Chief Scientific Officer at KalVista Pharmaceuticals, Inc. In this role, he is responsible for leading the company's research and development initiatives. His scientific expertise is essential for innovation and the development of new treatments.
